Phase I/II trial of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer
Dreicer R, Roth B, Petrylak D, Agus D, Meyers M, Esseltine D, Rodriquez D, Oppedisano P, Wang K, Boral A. Phase I/II trial of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer. Journal Of Clinical Oncology 2004, 22: 4654-4654. DOI: 10.1200/jco.2004.22.14_suppl.4654.Peer-Reviewed Original ResearchPhase I/II trialAndrogen-independent prostate cancerAdvanced androgen-independent prostate cancerII trialProstate cancerPatientsBortezomibDocetaxelCancerTrialsPhase I/II trial of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer
Dreicer R, Roth B, Petrylak D, Agus D, Meyers M, Esseltine D, Rodriquez D, Oppedisano P, Wang K, Boral A. Phase I/II trial of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer. Journal Of Clinical Oncology 2004, 22: 4654-4654. DOI: 10.1200/jco.2004.22.90140.4654.Peer-Reviewed Original ResearchPhase I/II trialAndrogen-independent prostate cancerAdvanced androgen-independent prostate cancerII trialProstate cancerPatientsBortezomibDocetaxelCancerTrials